Cargando…

Modeling Long-Term Erythropoietic Recovery After Allogeneic Stem Cell Transplants in Pediatric Patients

Long term erythropoietic reconstitution after allogeneic hematopoietic stem cell transplantation (alloHSCT) has not been extensively studied. We aimed to describe erythropoietic reconstitution as an indicator of long-term graft function by modeling hemoglobin levels during the first 3 years post HSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Asmuth, Erik G. J., Mohseny, Alexander B., Putter, Hein, Schilham, Marco W., Lankester, Arjan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734089/ https://www.ncbi.nlm.nih.gov/pubmed/33330281 http://dx.doi.org/10.3389/fped.2020.584156

Ejemplares similares

Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency
por: Gennery, Andrew R., et al.
Publicado: (2019)

Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in Children
por: van der Maas, Nicolaas G., et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies
por: Gennery, Andrew R., et al.
Publicado: (2019)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Optimizing diagnostic methods and stem cell transplantation outcomes in pediatric bone marrow failure: a 50-year single center experience
por: Vissers, Lotte, et al.
Publicado: (2023)

How to Facilitate Decision-Making for Hematopoietic Stem Cell Transplantation in Patients With Hemoglobinopathies. The Perspectives of Healthcare Professionals
por: Mekelenkamp, Hilda, et al.
Publicado: (2021)

PB1998: AZACYTIDINE AND ALLOGENOUS STEM CELL TRANSPLANTATION IN LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA
por: Fassi, Daniel El, et al.
Publicado: (2023)

Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
por: Zaidman, Irina, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)

Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years
por: Miśkiewicz-Bujna, Justyna, et al.
Publicado: (2022)

Long-term transplant outcomes after allogeneic hematopoietic transplant in pediatric patients with hematological malignancies are influenced by severe chronic graft vs. host disease and immune reconstitution
por: Molina, Blanca, et al.
Publicado: (2022)

Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation
por: Lawitschka, Anita, et al.
Publicado: (2021)

Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation
por: Garcia-Perez, Laura, et al.
Publicado: (2021)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022)

Editorial: Allogeneic haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia in the era of immunotherapy
por: Peters, Christina, et al.
Publicado: (2022)

Splenic rupture and fungal endocarditis in a pediatric patient with invasive fusariosis after allogeneic hematopoietic stem cell transplantation for aplastic anemia: A case report
por: Hannemann, Maurice, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
por: Truong, Tony H., et al.
Publicado: (2021)

The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency
por: Jeyaratnam, Jerold, et al.
Publicado: (2022)

Phenotypes and Baseline Risk Factors of Acute Kidney Injury in Children After Allogeneic Hematopoietic Stem Cell Transplantation
por: Daraskevicius, Justinas, et al.
Publicado: (2020)

Avatrombopag for the treatment of thrombocytopenia in children's patients following allogeneic hematopoietic stem-cell transplantation: A pilot study
por: Ruan, Yongsheng, et al.
Publicado: (2023)

Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review
por: Chen, Kai, et al.
Publicado: (2021)

Late Endocrine Effects After HSCT in Children With Nonmalignant Diseases; A Single Center Cohort Analysis
por: de Kloet, Liselotte C, et al.
Publicado: (2021)

UK experience of liver transplantation for erythropoietic protoporphyria
por: Dowman, Joanna K., et al.
Publicado: (2011)

The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization
por: Boelens, Jaap Jan, et al.
Publicado: (2020)

Case report: Application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation
por: Huang, Jinhua, et al.
Publicado: (2022)

Impact of donor age on short-term outcomes after pediatric split liver transplantation
por: Xu, Min, et al.
Publicado: (2023)

Vitamin D Supplementation: Association With Serum Cytokines in Pediatric Hematopoietic Stem Cell Transplantation
por: Olsen, Braden, et al.
Publicado: (2022)

Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009)

Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management
por: Vissers, Lotte T. W., et al.
Publicado: (2023)

Long-term erythropoietic repopulating ability of old, young, and fetal stem cells
Publicado: (1983)

Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions
por: Yanir, Asaf, et al.
Publicado: (2022)

Case Report: Immune Dysregulation Due to Toxoplasma gondii Reactivation After Allogeneic Hematopoietic Cell Transplant
por: Lindell, Robert B., et al.
Publicado: (2021)

A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults
por: Apsel Winger, Beth, et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs
por: Lobritto, Steven, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disease after pediatric kidney transplant
por: Fulchiero, Rosanna, et al.
Publicado: (2022)

Hypertension in the Pediatric Kidney Transplant Recipient
por: Charnaya, Olga, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i8t671r768vfllhpc45fsvdtic